Puma Biotechnology, Inc. (PBYI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 4.88 |
| Open | 4.87 |
| Bid | 4.99 x 200 |
| Ask | 5.04 x 400 |
| Day's range | 4.87 - 5.11 |
| 52-week range | 2.13 - 7.73 |
| Volume | |
| Avg. volume | 578,890 |
| Market cap | 242M |
| Beta (5Y monthly) | 1.31 |
| PE ratio (TTM) | 11.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
On Puma Biotechnology's (PBYI) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its sole marketed cancer drug, Nerlynx.
- Simply Wall St.
Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year
The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better...
- Zacks
Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
Puma Biotechnology (PBYI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
© 2024 Yahoo. All rights reserved.